Mutual Funds
Nippon India Pharma Fund - Growth
OVERVIEW FUND INFO PORTFOLIO

Morningstar Rating™
Not Rated

Morningstar® Category
India OE Specialty - Health
Total Net Assets (mil)
56,670.95 INR
Morningstar® Benchmark
S&P BSE Healthcare PR
Used throughout report
Fund Benchmark
S&P BSE Healthcare TR INR


RETURNS (%) FUND BENCHMARK CATEGORY
3M 6.87 6.85 8.27
6M 28.07 27.16 27.05
1Y 41.06 37.14 38.11
3Y* 24.95 19.46 25.61
5Y* 16.50 9.85 13.82
10Y* 19.32 16.30 18.06
*Annualised Return Data Through 23/09/2021
QUARTERLY RETURNS (%) Q1 Q2 Q3 Q4
2021 -1.15 22.06- -
2020 -5.70 31.5919.50 12.24
2019 1.48 -6.51 -1.11 8.38
2018 -7.35 6.93 10.70 -5.50
2017 0.87 -4.95 0.19 12.03
RISK MEASURES
3Y Alpha 6.58
3Y Beta 0.88
3Y R-Squared 95.17
3Y Info Ratio 1.25
3Y Tracking Error 5.10
3Y Sharpe Ratio 1.03
3Y Std Dev 19.96
3Y Risk -
5Y Risk -
10Y Risk -
Calculations use S&P BSE Healthcare PR (where applicable)

Morningstar Style BoxTM


* Report as of 24 Sep 2021


© 2021 Morningstar. All Rights Reserved.

Disclaimer :
© 2021 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein: (1) include the proprietary information of Morningstar and Morningstar’s third party licensors; (2) may not be copied or redistributed except as specifically authorised;(3) do not constitute investment advice;(4) are provided solely for informational purposes; (5) are not warranted to be complete, accurate or timely; and (6) may be drawn from fund data published on various dates. Morningstar is not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.